Pelosi Applauds Provisions in Health Bill to Improve Access to Care, Medications for People Living With HIV/AIDS
|
| Posted
:
Mon, 09 Nov 2009 16:10:29 GMT |
| Author
:
Office of the Speaker of the House |
| Category
:
Press Release |
| News Alerts by
Email ( click
here ) |
|
|
|
|
WASHINGTON, Nov. 9 /PRNewswire-USNewswire/ -- Speaker Nancy Pelosi released the following statement praising provisions in the Affordable Health Care for America Act (H.R. 3962) that will improve access to Medicaid and reduce Medicare Part D costs for people living with HIV/AIDS. H.R. 3962 passed the House on Saturday by a vote of 220 to 215:
"Effective drug treatments have improved both health and quality of life for thousands of Americans living with HIV/AIDS. However, many uninsured, low-income HIV-positive individuals still do not have access to these life-saving medications because they generally do not meet Medicaid requirements until becoming disabled by full-blown AIDS.
"Forcing people with HIV to wait for health care until their immune system is compromised by AIDS is bad health policy. The House health insurance reform bill dramatically increases access to Medicaid for all low-income Americans, including people living with HIV, by covering everyone up to 150 percent of the federal poverty level.
"For more than a decade, I have worked to expand access to Medicaid for people living with HIV through the Early Treatment for HIV Act. With Saturday's passage of the Affordable Health Care for America Act, the House has moved a step closer to not just achieving this goal, but exceeding it."
Background:
Currently, childless adults without a disability typically do not qualify for Medicaid at any income level. But even for parents and disabled adults eligibility is generally limited to those with incomes below 100 percent of the poverty level, and in many states the threshold is much lower.
The bill's expanded access to Medicaid begins in January 2013, when the new Health Insurance Exchange begins operation. In the interim, H.R. 3962 further ensures early access to care and treatment for people living with HIV by giving states the option of an enhanced federal match if they choose to cover people with HIV in their existing Medicaid programs. In participating states, people with HIV infection would qualify for coverage using the same eligibility standards that currently apply for disabled adults.
In addition, H.R. 3962 also finally allows medications provided through the AIDS Drug Assistance Program (ADAP) to count toward out-of-pocket costs in the Medicare Part D 'donut hole'. Prior to this change, ADAP beneficiaries would enter the "donut hole" coverage gap and then never leave it because their drug costs weren't being counted.
Now, ADAP beneficiaries will exit the "donut hole" more quickly, giving them access to the full range of medications covered under Medicare Part D. This is important because ADAP programs generally have a more limited formulary than the typical Medicare Part D plan.
SOURCE Office of the Speaker of the House
|
Copyright © 2008
PR Newswire. All rights reserved.
|
|
|
|
|
Related
News
MedPro Safety Products Reports Recent Progress LEXINGTON, Ky. -
MedPro Safety Products, Inc. (OTCBB: MPSP), a pioneer in the development
and marketing of passive needlestick injury prevention technology, today
reported on the Company’s recent progress.
The recent highlights include:
Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain
NOVATO, Calif., Nov. 23 -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTP) today announced the presentation of clinical trial data on NGX426, the Company's orally administered, non-opioid, AMPA/kainate receptor antagonist...
AngioDynamics to Participate in the 21st Annual Piper Jaffray Health Care Conference QUEENSBURY, N.Y. -
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical
devices for the minimally-invasive treatment of cancer and peripheral
vascular disease, announced today that it will present at the 21st
Annual Piper Jaffray Health Care Conference in New York
Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis
NOVATO, Calif., Nov. 23 -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTP), today announced results from a Phase 2b clinical trial of its proprietary delayed-release cysteamine bitartrate ("DR Cysteamine") i...
Rainmaker Signs Global Employment Screening Company as New Client for Lead Development
CAMPBELL, Calif., Nov. 23 -- Rainmaker Systems, Inc. (Nasdaq: RMKR), a leading provider of sales and marketing solutions offering hosted application software and execution services, today announced it has signed a one-year agreement for lead development services w...
Macquarie Infrastructure Company Enters into Agreement to Sell Minority Stake in District Energy Business NEW YORK -
Macquarie Infrastructure Company (NYSE: MIC) announced that it has
entered into an agreement to sell a 49.99% interest in its district
energy business, Thermal Chicago, to an affiliate of The John Hancock
Life Insurance Company for $29.5 million.
The Company
Zaldiva Announces the Engagement of a Wall Street Investment Banking Firm for an Initial 12 Month Period Plus Extension
FORT LAUDERDALE, Fla., Nov. 23 -- Zaldiva, Inc. (OTC Bulletin Board: http://finance.yahoo.com/q?s=zldv.obZLDV) (XETRA: UZ8DE.DEhttp://finance.yahoo.com/q?s=uz8de...
|
|
|
|
|
|
|
|
|